Key figures
-
21.0
billion euro net sales in 2023
-
5.9
billion euro EBITDA pre in 2023
-
63000
employees around the world
Latest News
View all news-
Press Releases
Merck KGaA, Darmstadt, Germany, Exercises Option for Commercialization of Pimicotinib
The company today announced it has exercised its option with Abbisko for commercialization of pimicotinib in the U.S. and rest of world.
2025/03/28
-
Press Releases
Collaboration with Zebra Technologies to Create Safety and Traceability Solutions
We announced a new collaboration with Zebra Technologies today to address challenges around product verification, authenticity, and trust.
2025/03/27
-
Press Releases
Full-year 2024: Delivering Profitable Growth
The Group returned to profitable growth in 2024 and delivered on its guidance for the year.
2025/03/06
Stay up-to-date
You want to receive the latest information about our company by e-mail? Then subscribe to our press releases: Subscribe
-
Media Contacts
Get in touch!for journalists, bloggers or multipliers.
-
Media downloads
Browse and download high-quality images and video footage.Access gallery -
Press Kits
Collected Topicswith all the facts and relevant background information on particularly important topics.
This might also interest you
-
Strategy & Values
Learn moreWe believe in science and technology as a force for good.
-
Stories
Learn moreLearn more about our company and the people behind it.
-
Sustainability
Learn moreWe want to create long-term added value for society.
-
Our sites
Learn moreLearn where you can find us around the world.
EVEN MORE INFORMATION
Upcoming Events
View All Events25 Apr 2025
Annual General Meeting 2025
The Annual General Meeting of Merck KGaA, Darmstadt, Germany will take place on April 25, 2024.
Our Q1 2025 results will be published on May 15, 2025, at 7 a.m. (CET). Our conference call for the media will take place at 10:00 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).